SiteStat.jsp
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, 45
To order this title, and for more information, click here
John Macor , Neuroscience Discovery Chemistry, Bristol-Myers Squibb, USA
Included in series
Annual Reports in Medicinal Chemistry,
Contents
1 Recent advances in the discovery of GSK-3 inhibitors and a
perspective on their utility for the treatment of Alzheimer's
disease
Robert G. Gentles, Shuanghua Hu,
and. Gene Dubowchik
2 Advances in the Development of Nitric
Oxide Synthase Inhibitors
Shawn Maddaford, Subhash
Annendi, Jailall Remnauth, and
Suman Rakhit
3
Small Molecule Protein?Protein Interaction Inhibitors as
Therapeutic Agents for Neurodegenerative Diseases: Current
Progress
and Future Hurdles
Simon Haydar and Warren Hirst
4 Case History: Chantix (varenicline tartrate) a Nicotinic Partial
Agonist Aid to Smoking Cessation
Jotham W. Coe, Hans Rollema and
Brian T. O'Neill
5 Case History on
Tekturna /Rasilez (Aliskiren), a Highly
Efficacious Direct Oral Renin Inhibitor as a New Therapy for
Hypertension
Juergen Maibaum and David Feldman
6 Advances in Vasopressin Receptor Agonists and Antagonists Thomas Ryckmans
7 The Emergence of GPR119 Agonists as Anti-diabetic Agents Robert Jones
8 Non-peptide Ligands for the Gonadotropin
Receptors Nicole van Straten, Marco Timmers
9 Recent Advances in Coagulation Serine Protease Inhibitors
Mimi Quan
and Joanne Smallheer
10 Advances in the Discovery of Anti-Inflammatory FMS Inhibitors Mark Player and Carl Manthey
11 Recent Advances in the Discovery of CB2 Selective Agonists Jayant Thatte, Sangdon Han, and Rob Jones
12
Advances in the Discovery of Small Molecule JAK3 Inhibitors Stephen Wrobleski
13 Recent Advances in Adenosine Receptor
(AR) Ligands in
Pulmonary Diseases
Jeff Zablocki and Rao Kalla
14 Recent Progress in the Development of
Small Molecule Inhibitors
of Insulin-like Growth Factor Receptor (IGF-1R) Kinase Dinesh Vyas and Mark Wittman
15
Case History: Discovery of Ixabepilone (IXEMPRA[TM]), a First-inclass
Epothilone Analogue for Treatment of Metastatic Breast Cancer
Robert M. Borzilleri and Gregory D.
16 Hedgehog Signaling Pathway Inhibitors as Cancer Therapeutics Stefan Peuker and
Karen Miller-Moslin
17 Emerging Therapies Based on Inhibitors of Phosphatidyl-Inositol-
3-Kinases (PI3Ks)
John M. Nuss, Amy Lew Tsuhako
and Neel K. Anand Exelixis
18 Anti-infective Activity of Artemisinin and its Semi-synthetic
Derivatives John G. D'Angelo
19 Recent Advances in the Inhibition of Bacterial Type II
Topoisomerases
Greg
Bisacchi & Jacques Dumas
20 Progress Towards the Discovery and Development of Specifically
Targeted Inhibitors
of Hepatitis C Virus
Nicholas A. Meanwell John F.
Kadow and Paul M. Scol
21 Inhibitors of Nuclear Hormone
Receptor/Steroid Receptor
Coactivator Interactions
Terry Moore, John Katzenellenbogen
22 Safety Testing
of Drug Metabolites Tom Thompson
23 A Path to Innovation: Gene Knockouts Model New Drug Action Brian Zambrowicz
24 Discovery of Novel Positron Emission Tomography (PET) Tracers Dennis McCarthy
25 The Use of Isotopically
Labeled Compounds in Drug Discovery (Chad) Charles S. Elmore
26 Mechanism based inhibition of CYP3A4 and other cytochromes
P450 Bernard Murray
27 Nonclinical Toxicogenomics in the Pharmaceutical Environment Bruce D. Car
28 To
Market, To Market 2008 Shridhar Hegde and Michelle Schmidt
Bibliographic details
Paperback, 0 pages, publication date: NOV-2010
ISBN-13: 978-0-12-380902-5
Imprint: ACADEMIC PRESS
Price and Ordering
Price:
GBP 75 USD 150 EUR 110
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
See also information about conditions of sale & ordering procedures , and links to our regional sales offices .
030/302
Last update: 30 Nov 2009